Skip to main content
logo
Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.000
-0.200 (-4.76%)
Jun 16, 2026, 2:53 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Discovering, Developing and Commercializing New Class of Innovative Medicines
66.86M107.81M---
Discovering, Developing and Commercializing New Class of Innovative Medicines Growth
-37.99%----
Pharmaceuticals
---2.28M12.16M
Pharmaceuticals Growth
----81.28%-
Total
66.86M107.81M-2.28M12.16M
Total Growth
-37.99%---81.28%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
People's Republic of China
66.86M107.81M-2.28M12.16M
People's Republic of China Growth
-37.99%---81.28%-
Total
66.86M107.81M-2.28M12.16M
Total Growth
-37.99%---81.28%-